This review highlights several key pathways involved in resistance in advanced melanoma, including the PI3K/AKT/mTOR and JAK-STAT pathways, as well as the crucial roles of APCs, MHC molecules, IFN-γ, VEGF, and endothelins, among others. This evidence concerns the gene MTOR and melanoma.